Apricitabine: Phase IIb data

In the double-blind Phase IIb AVX-201 trial in 47 treatment-experienced HIV patients with the M184V mutation, apricitabine met the

Read the full 195 word article

How to gain access

Continue reading with a
two-week free trial.